Mulmit

Replimune Group, Inc.Replimune Group, Inc.

REPL Nasdaq

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-20Astley-Sparke Philip50,000
2026-08-17Hill Emily LuisaChief Financial Officer9,256
2026-08-11BAKER BROS. ADVISORS LP126,394
2026-08-11BAKER BROS. ADVISORS LP2,609,946
2026-08-10Patel SushilChief Executive Officer39,341
2026-08-10Hill Emily LuisaChief Financial Officer11,448
2026-08-10Xynos KonstantinosChief Medical Officer11,447
2026-08-10Schwendenman AndrewChief Accounting Officer7,632
2026-06-01Sarchi ChristopherChief Commercial Officer12,000
2026-05-18Xynos KonstantinosChief Medical Officer14,023
2026-05-18Schwendenman AndrewChief Accounting Officer7,894
2026-05-18Sarchi ChristopherChief Commercial Officer8,626

8-K events

FiledItems
2026-09-16Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-08-14Results of operations · Financial statements and exhibits
2026-08-11Other events · Financial statements and exhibits
2026-08-10Other events · Financial statements and exhibits
2026-08-07Other events · Financial statements and exhibits
2026-07-31Other events · Financial statements and exhibits
2026-07-30Regulation FD disclosure · Financial statements and exhibits
2026-06-29Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…